Clinical trial Recruiting at 7 sites Interventional Ages 18 and up

Evaluation of GORE® ENFORM Biomaterial for Hernia Repair

Official title: GORE® ENFORM Biomaterial Product Study: A Study to Describe Multi-use Biomaterial Performance in Hernia Patients

Run by W.L.Gore & Associates · NCT04718168 · Data updated 2026-11-12

This study is testing a new material for hernia repair to see how well it works and how patients feel about it after surgery.

More Incisional Hernia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment245 (estimated)
SponsorW.L.Gore & Associates
Industry-sponsored
Drugs / interventionsradiation
Locations9 sites (San Diego, California and 8 other locations)
StatusRecruiting
StartedMay 17, 2021
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 27, 2026
Trial IDNCT04718168 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who require surgical repair of a single site ventral or hiatal hernia.

Probably not a fit

Patients with complex hernia repairs or those who have been involved in other clinical studies within the past year may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the GORE® ENFORM Biomaterial in patients undergoing repair for various types of hernias, including ventral, hiatal, and diaphragmatic hernias. It is a multicenter, non-randomized study that collects data on the functional performance of the biomaterial and the short-term patient experience. Participants will be monitored for their surgical outcomes and overall satisfaction with the treatment. The study aims to provide insights into the effectiveness of this biomaterial in hernia repair procedures.

Why it matters

Potential benefit: If successful, this study could improve surgical outcomes and patient satisfaction in hernia repair procedures.

How similar studies have gone: Other studies have shown promising results with similar biomaterials in hernia repair, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Pre-procedure Inclusion Criteria:

The subject is / has:

1. At least 18 years old at the time of informed consent. Minimum age required by state regulations (as applicable).
2. An expected scored Class I (Clean) surgical wound using CDC Surgical Wound Classification system.
3. A planned implant with GORE® ENFORM Biomaterial for a single site ventral or hiatal hernia repair as suture line reinforcement.
4. An expected scored Grade 1 or Grade 2 using the Ventral Hernia Working Group Grading system.
5. Willing to provide informed consent and comply with follow-up requirements.

Pre-procedure Exclusion Criteria:

The subject is / has:

1. Treated in another drug or medical device study within 1 year of study enrollment.
2. Implanted with GORE® ENFORM Biomaterial in the reconstruction of cardiovascular defects.
3. Hernia repair expected to be performed as part of a bridged procedure (i.e., expected inability to perform primary closure of fascia or crura, patients requiring permanent support from the device).
4. A BMI \>40.
5. Evidence of a systemic infection.
6. Cirrhosis or undergoing dialysis.
7. A wound-healing disorder.
8. Immunocompromised such as, with HIV or transplant, or receiving chemo or radiation therapy.
9. Expected to undergo mesh implantation in conjunction with any bariatric procedure and / or panniculectomy procedure.
10. A stoma.
11. Co-morbid conditions that may limit their ability to comply with study and follow-up requirements.
12. Positive pregnancy or lactation status as confirmed by site standard of care.
13. Hernias requiring treatment within multiple body regions or expected use of multiple hernia mesh devices.

Post-procedure Inclusion Criteria

At the time of index procedure, the subject is / has:

1. At least 18 years old. Minimum age required by state regulations (as applicable).
2. Implanted with GORE® ENFORM Biomaterial for a single site ventral or hiatal hernia repair as suture-line reinforcement on or before 365 days prior to site protocol amendment 3 approval date.
3. Unless there is an Informed Consent waiver issued by the Institutional Review Board (IRB), an Informed Consent Form (ICF) signed by subject.

Post-procedure Exclusion Criteria

At the time of index procedure, the subject is / has:

1. Treated in another drug or medical device study within 1 year of study enrollment.
2. Implanted with GORE® ENFORM Biomaterial in the reconstruction of cardiovascular defects.
3. Hernia repair that was performed as part of a bridged procedure (i.e., inability to perform primary closure of fascia or crura, patients requiring permanent support from the device).
4. A BMI \>40.
5. Evidence of a systemic infection.
6. Cirrhosis or undergoing dialysis.
7. A wound-healing disorder.
8. Immunocompromised such as, with HIV or transplant, or receiving chemo or radiation therapy.
9. Underwent mesh implantation in conjunction with any bariatric procedure and / or panniculectomy procedure.
10. A stoma.
11. Co-morbid conditions that may limit their ability to comply with study and follow-up requirements.
12. Positive pregnancy or lactation status as confirmed by site standard of care.
13. Hernias requiring treatment within multiple body regions or expected use of multiple hernia mesh devices.

Where it's running

  • University of California - San Diego
    San Diego, California, United States
    Recruiting
  • Institute of Esophageal and Reflux Surgery
    Denver, Colorado, United States
    Recruiting
  • Northshore University Health System Research Institute
    Evanston, Illinois, United States
    Recruiting
  • University of Kentucky
    Lexington, Kentucky, United States
    Recruiting
  • Prisma Health - Upstate
    Greenville, South Carolina, United States
    Recruiting
  • University of Texas Health Science Center at Houson
    Houston, Texas, United States
    Recruiting
Show 3 more locations
  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting
  • Sarasota Memorial HealthCare System
    Sarasota, Florida, United States
    Completed
  • Atrium Health
    Charlotte, North Carolina, United States
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.